Medirom Healthcare Technologies Inc. financials

Medirom Healthcare Technologies Inc. reports to SEC EDGAR in JPY (it files a 20-F/40-F as a foreign private issuer), so every monetary figure below is in JPY as filed, not US dollars.
MRM CIK 0001819704

Source: EDGAR filings · Built 2026-06-19T01:16:07Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2024FY 2023FY 2022FY 2021FY 2020FY 2020
Free Cash Flow -1.40B -767.58M -806.44M -652.88M -439.98M 464.00K
EBITDA 271.94M -138.98M 281.02M -344.34M -683.80M 80.52M
Working Capital -1.48B -1.80B -1.28B -1.81B -565.36M -883.96M
Net Debt 3.63B 4.59B 3.78B 2.42B 1.12B 1.70B
Gross Margin 27.07% 22.98% 27.36%
Operating Margin -0.22% -5.73% 1.39% -8.70% -22.33% 0.88%
Net Margin 1.79% 1.69% 2.14% -18.31% -16.14% 0.44%
Return on Equity (ROE) 15.94% 54.73% -250.88% 475.53% -109.75% 2.89%
Return on Assets (ROA) 1.84% 1.68% 2.21% -17.22% -9.44% 0.36%
Current Ratio 0.65× 0.49× 0.65× 0.43× 0.79× 0.61×
Debt-to-Equity 4.24× 22.29× -73.78× -13.40× 5.21× 3.69×
Effective Tax Rate -189.63% -457.89% 17.14% -139.03% 13.97% 48.76%
Cash Conversion Ratio -8.95× -5.47× -4.60× 0.56× 0.68× 0.45×
Accruals Ratio 0.18× 0.11× 0.12× -0.08× -0.03× 0.00×
SBC % of Revenue 3.64%
CapEx Coverage -18.65× -4.65× -5.68× -5.83× -4.98× 1.06×
Free Cash Flow Per Share ¥-239.78 ¥-148.56 ¥-147.41 ¥-133.86 ¥-109.32 ¥0.11

Income Statement

Concept FY 2024FY 2023FY 2022FY 2021FY 2020FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 8.30B 6.83B 6.95B 5.41B 3.34B 3.91B
Cost of Revenue 6.05B 5.26B 5.05B
Gross Profit 2.25B 1.57B 1.90B
Selling, General and Administrative Expense 2.24B 1.96B 1.81B 1.82B 1.07B 871.86M
Operating Income (Loss) -18.10M -391.58M 96.97M -470.59M -746.09M 34.35M
Income Tax Expense (Benefit) -90.48M -94.43M 30.81M 576.25M -87.52M 15.96M
Net Income (Loss) Attributable to Parent 148.76M 115.40M 148.97M -990.73M -539.17M 17.34M
Earnings Per Share, Basic ¥29.13 ¥23.64 ¥30.54 ¥-203.13 ¥-133.97 ¥4.63
Weighted Average Number of Shares Outstanding, Basic 5.11M 4.88M 4.88M 4.88M 4.02M 3.75M
Earnings Per Share, Diluted ¥28.52 ¥22.34 ¥27.23 ¥-203.13 ¥-133.97 ¥4.06
Weighted Average Number of Shares Outstanding, Diluted 5.85M 5.17M 5.47M 4.88M 4.02M 4.27M

Balance Sheet

Concept FY 2024FY 2023FY 2022FY 2021FY 2020FY 2020
Cash and Cash Equivalents, at Carrying Value 2.09M 755.00K 4.59M 370.62M 1.44B 513.62M
Assets, Current 2.71B 1.76B 2.36B 1.38B 2.09B 1.38B
Assets 8.09B 6.85B 6.75B 5.75B 5.71B 4.76B
Long-term Debt 1.39B 1.15B 1.25B 908.84M 910.66M 342.10M
Liabilities, Current 4.18B 3.56B 3.64B 3.20B 2.65B 2.26B
Long-term Debt, Excluding Current Maturities 764.20M 1.05B 1.15B 746.59M 668.38M 150.53M
Liabilities 6.90B 6.63B 6.81B 5.96B 5.22B
Stockholders' Equity Attributable to Parent 933.27M 210.88M -59.38M -208.34M 491.26M 600.06M
Common Stock, Shares, Outstanding 7.90M

Cash Flow Statement

Concept FY 2024FY 2023FY 2022FY 2021FY 2020FY 2020
Net Cash Provided by (Used in) Operating Activities -1.33B -631.74M -685.70M -557.23M -366.42M 7.87M
Payments to Acquire Property, Plant, and Equipment 71.41M 135.84M 120.74M 95.65M 73.56M 7.41M
Net Cash Provided by (Used in) Investing Activities 361.39M -328.58M 580.44M -83.94M -139.60M -37.93M
Net Cash Provided by (Used in) Financing Activities 1.19B 461.21M 340.10M -427.95M 1.43B 331.99M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MRM CIK 0001819704), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IFF

INTERNATIONAL FLAVORS & FRAGRANCES INC

SAFX

XCF GLOBAL, INC.

BDCIW

BTC DEVELOPMENT CORP.